229 related articles for article (PubMed ID: 27388992)
1. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Remington J; Chen M; Burnett J; Woodley DT
Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
[TBL] [Abstract][Full Text] [Related]
4. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
5. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
Front Immunol; 2019; 10():3012. PubMed ID: 31993051
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
Hellberg L; Samavedam UKSRL; Holdorf K; Hänsel M; Recke A; Beckmann T; Steinhorst K; Boehncke WH; Kirchner T; Möckel N; Solbach W; Zillikens D; Schmidt E; Ludwig RJ; Laskay T
J Invest Dermatol; 2013 Oct; 133(10):2390-2399. PubMed ID: 23448878
[TBL] [Abstract][Full Text] [Related]
10. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
12. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
Ludwig R
Expert Rev Clin Immunol; 2015; 11(12):1365-78. PubMed ID: 26471717
[TBL] [Abstract][Full Text] [Related]
14. Experimental models of epidermolysis bullosa acquisita.
Sitaru C
Exp Dermatol; 2007 Jun; 16(6):520-31. PubMed ID: 17518993
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
Akbarzadeh R; Yu X; Vogl T; Ludwig RJ; Schmidt E; Zillikens D; Petersen F
J Dermatol Sci; 2016 Mar; 81(3):165-72. PubMed ID: 26692467
[TBL] [Abstract][Full Text] [Related]
16. Epidermolysis bullosa acquisita.
Cobos G; Mu E; Cohen J; Beasley J; Brinster N; Femia A
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447655
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
[TBL] [Abstract][Full Text] [Related]
19. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.
Koga H; Kasprick A; López R; Aulí M; Pont M; Godessart N; Zillikens D; Bieber K; Ludwig RJ; Balagué C
Front Immunol; 2018; 9():1558. PubMed ID: 30050528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
